Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma
Although the majority of patients with myeloma who achieve undetectable minimal residual disease show prolonged survival, some of them relapse shortly afterwards. False negative results due to hemodiluted bone marrow samples can be one explanation. This paper investigates how to evaluate hemodilution.